LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Patients with an episode of depression in late life prescribed mirtazapine recruited from a
clinical sample will be monitored for weight and receive a blood test during their usual
course of treatment to determine polymorphisms in a specific gene (LEPR) thought to affect
weight gain.